Literature DB >> 28886013

Secondary bacterial infections and antibiotic resistance among tungiasis patients in Western, Kenya.

Ruth Monyenye Nyangacha1,2, David Odongo2, Florence Oyieke2, Missiani Ochwoto3, Richard Korir4, Ronald Kiprotich Ngetich4, Gladys Nginya1, Olipher Makwaga5, Christine Bii4, Peter Mwitari1, Festus Tolo1.   

Abstract

Tungiasis or jigger infestation is a parasitic disease caused by the female sand flea Tunga penetrans. Secondary infection of the lesions caused by this flea is common in endemic communities. This study sought to shed light on the bacterial pathogens causing secondary infections in tungiasis lesions and their susceptibility profiles to commonly prescribed antibiotics. Participants were recruited with the help of Community Health Workers. Swabs were taken from lesions which showed signs of secondary infection. Identification of suspected bacteria colonies was done by colony morphology, Gram staining, and biochemical tests. The Kirby Bauer disc diffusion test was used to determine the drug susceptibility profiles. Out of 37 participants, from whom swabs were collected, specimen were positive in 29 and 8 had no growth. From these, 10 different strains of bacteria were isolated. Two were Gram positive bacteria and they were, Staphylococcus epidermidis (38.3%) and Staphylococcus aureus (21.3%). Eight were Gram negative namely Enterobacter cloacae (8.5%), Proteus species (8.5%), Klebsiellla species (6.4%), Aeromonas sobria (4.3%), Citrobacter species (4.3%), Proteus mirabillis(4.3%), Enterobacter amnigenus (2.1%) and Klebsiella pneumoniae (2.1%). The methicillin resistant S. aureus (MRSA) isolated were also resistant to clindamycin, kanamycin, erythromycin, nalidixic acid, trimethorprim sulfamethoxazole and tetracycline. All the Gram negative and Gram positive bacteria isolates were sensitive to gentamicin and norfloxacin drugs. Results from this study confirms the presence of resistant bacteria in tungiasis lesions hence highlighting the significance of secondary infection of the lesions in endemic communties. This therefore suggests that antimicrobial susceptibility testing may be considered to guide in identification of appropriate antibiotics and treatment therapy among tungiasis patients.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28886013      PMCID: PMC5607213          DOI: 10.1371/journal.pntd.0005901

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


  29 in total

1.  Jiggers outbreak in Uganda.

Authors:  Kennedy Jawoko
Journal:  CMAJ       Date:  2011-01-11       Impact factor: 8.262

2.  Antibiotic resistance-the need for global solutions.

Authors:  Ramanan Laxminarayan; Adriano Duse; Chand Wattal; Anita K M Zaidi; Heiman F L Wertheim; Nithima Sumpradit; Erika Vlieghe; Gabriel Levy Hara; Ian M Gould; Herman Goossens; Christina Greko; Anthony D So; Maryam Bigdeli; Göran Tomson; Will Woodhouse; Eva Ombaka; Arturo Quizhpe Peralta; Farah Naz Qamar; Fatima Mir; Sam Kariuki; Zulfiqar A Bhutta; Anthony Coates; Richard Bergstrom; Gerard D Wright; Eric D Brown; Otto Cars
Journal:  Lancet Infect Dis       Date:  2013-11-17       Impact factor: 25.071

3.  [Tungiasis and tetanus at the University Hospital Center in Brazzaville].

Authors: 
Journal:  Dakar Med       Date:  1989

4.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.

Authors:  Yves Gillet; Bertrand Issartel; Philippe Vanhems; Jean-Christophe Fournet; Gerard Lina; Michèle Bes; François Vandenesch; Yves Piémont; Nicole Brousse; Daniel Floret; Jerome Etienne
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

5.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

6.  Genetic background and antibiotic resistance of Staphylococcus aureus strains isolated in the Republic of Georgia.

Authors:  Tamara Revazishvili; Lela Bakanidze; Tsaro Gomelauri; Ekaterine Zhgenti; Gvantsa Chanturia; Merab Kekelidze; Chythanya Rajanna; Arnold Kreger; Alexander Sulakvelidze
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

7.  Investigations into the mechanism of action of the antibacterial agent norfloxacin.

Authors:  G C Crumplin; M Kenwright; T Hirst
Journal:  J Antimicrob Chemother       Date:  1984-05       Impact factor: 5.790

8.  Bacterial superinfection in human tungiasis.

Authors:  H Feldmeier; J Heukelbach; M Eisele; A Queiroz Sousa; L Marilac Meireles Barbosa; C B M Carvalho
Journal:  Trop Med Int Health       Date:  2002-07       Impact factor: 2.622

9.  Once versus thrice daily gentamicin in patients with serious infections.

Authors:  J M Prins; H R Büller; E J Kuijper; R A Tange; P Speelman
Journal:  Lancet       Date:  1993-02-06       Impact factor: 79.321

10.  Investigations on the biology, epidemiology, pathology and control of Tunga penetrans in Brazil: IV. Clinical and histopathology.

Authors:  Hermann Feldmeier; Margit Eisele; Eric Van Marck; Heinz Mehlhorn; Ronaldo Ribeiro; Jörg Heukelbach
Journal:  Parasitol Res       Date:  2004-10       Impact factor: 2.289

View more
  7 in total

1.  Phenotypic and genotypic characterization of clinical Staphylococcus aureus isolates from Kenya.

Authors:  Cecilia Kyany'a; Justin Nyasinga; Daniel Matano; Valerie Oundo; Simon Wacira; Willie Sang; Lillian Musila
Journal:  BMC Microbiol       Date:  2019-11-06       Impact factor: 3.605

2.  Mapping the Geographic Distribution of Tungiasis in Sub-Saharan Africa.

Authors:  Mark A Deka
Journal:  Trop Med Infect Dis       Date:  2020-07-24

Review 3.  The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.

Authors:  Shamshul Ansari; John P Hays; Andrew Kemp; Raymond Okechukwu; Jayaseelan Murugaiyan; Mutshiene Deogratias Ekwanzala; Maria Josefina Ruiz Alvarez; Maneesh Paul-Satyaseela; Chidozie Declan Iwu; Clara Balleste-Delpierre; Ed Septimus; Lawrence Mugisha; Joseph Fadare; Susmita Chaudhuri; Vindana Chibabhai; J M Rohini W W Wadanamby; Ziad Daoud; Yonghong Xiao; Thulasiraman Parkunan; Yara Khalaf; Nkuchia M M'Ikanatha; Maarten B M van Dongen
Journal:  JAC Antimicrob Resist       Date:  2021-04-08

4.  Detection of Free-Living Amoebae and Their Intracellular Bacteria in Borehole Water before and after a Ceramic Pot Filter Point-of-Use Intervention in Rural Communities in South Africa.

Authors:  Clarissa van der Loo; Catheleen Bartie; Tobias George Barnard; Natasha Potgieter
Journal:  Int J Environ Res Public Health       Date:  2021-04-08       Impact factor: 3.390

5.  Efficacy of oral fluralaner (Bravecto) against Tunga penetrans in dogs: A negative control, randomized field study in an endemic community in Brazil.

Authors:  Katharine Costa Dos Santos; Rafael Marin Chiummo; Anja Regina Heckeroth; Eva Zschiesche; Paula Elisa Brandão Guedes; Tatiani Vitor Harvey; Anderson Vieira de Jesus; Anaiá da Paixão Sevá; Joana Thaisa Santos de Oliveira; Zelina Dos Santos Freire; Jürgen Krücken; Fernando de Almeida Borges; Georg von Samson-Himmelstjerna; Renata Santiago Alberto Carlos
Journal:  PLoS Negl Trop Dis       Date:  2022-03-14

6.  Efficacy of diversely isolated lytic phages against multi-drug resistant Enterobacter cloacae isolates in Kenya.

Authors:  Ivy J Mutai; Angela A Juma; Martin I Inyimili; Atunga Nyachieo; Anthony K Nyamache
Journal:  Afr J Lab Med       Date:  2022-08-11

Review 7.  Secondary Bacterial Infections During Pulmonary Viral Disease: Phage Therapeutics as Alternatives to Antibiotics?

Authors:  Prasanth Manohar; Belinda Loh; Sudarsanan Athira; Ramesh Nachimuthu; Xiaoting Hua; Susan C Welburn; Sebastian Leptihn
Journal:  Front Microbiol       Date:  2020-06-26       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.